{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Methods: In this randomized controlled trial, elderly patients (aged \u2265 60 years) undergoing elective TKA were randomly allocated in a 1:1:1 ratio to 0.6 \u03bcg/kg/h dexmedetomidine (Group D2), 0.3 \u03bcg/kg/h dexmedetomidine (Group D1) and saline (Group N)."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Methods: In this randomized controlled trial, elderly patients (aged \u2265 60 years) undergoing elective TKA were randomly allocated in a 1:1:1 ratio to 0.6 \u03bcg/kg/h dexmedetomidine (Group D2), 0.3 \u03bcg/kg/h dexmedetomidine (Group D1) and saline (Group N)."
      },
      "Participants": {
        "score": 2,
        "evidence": "elderly patients (aged \u2265 60 years) undergoing elective TKA"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomly allocated in a 1:1:1 ratio to 0.6 \u03bcg/kg/h dexmedetomidine (Group D2), 0.3 \u03bcg/kg/h dexmedetomidine (Group D1) and saline (Group N)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to determine the effects of different doses of dexmedetomidine on postoperative QoR in elderly TKA patients, and whether there is a correlation with specific EEG changes."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "On postoperative days 1 and 3, the15-item Quality of Recovery (QoR-15) scale was used to evaluate the postoperative recovery of patients among the three groups."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "randomly allocated in a 1:1:1 ratio"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The difference of QoR-15 scores on postoperative day 1 was significant for Group D2 vs Group N (126 [123\u2013129] points vs 120 [116\u2013123] points; median difference, 6 points [95% CI, 4 to 8]; P < 0.001) and Group D2 vs Group D1 (126 [123\u2013129] points vs 122 [118\u2013126]; median difference, 4 points [95% CI, 2 to 5]; P = 0.001)"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}